1. Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature. (4th November 2015) Authors: Linch, Stefanie; Kasiewicz, Melissa J; McNamara, Michael; Hilgart, Ian; Farhad, Mohammad; Redmond, William Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Multispectral imaging of T and B cells in murine tissue. (4th November 2015) Authors: Feng, Zipei; Farhad, Mohammad; Fox, Bernard A; Jensen, Shawn Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T cell anergy and promotes survival in tumor-bearing mice. (4th November 2015) Authors: Linch, Stefanie; Kasiewicz, Melissa J; McNamara, Michael; Hilgart-Martiszus, Ian; Farhad, Mohammad; Redmond, William Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T cell anergy and promotes survival in tumor-bearing mice. Issue 2 (December 2015) Authors: Linch, Stefanie; Kasiewicz, Melissa; McNamara, Michael; Hilgart-Martiszus, Ian; Farhad, Mohammad; Redmond, William Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature. Issue 2 (December 2015) Authors: Linch, Stefanie; Kasiewicz, Melissa; McNamara, Michael; Hilgart, Ian; Farhad, Mohammad; Redmond, William Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Multispectral imaging of T and B cells in murine tissue. Issue 2 (December 2015) Authors: Feng, Zipei; Farhad, Mohammad; Fox, Bernard; Jensen, Shawn Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment. (3rd June 2018) Authors: Farhad, Mohammad; Rolig, Annah S.; Redmond, William L. Journal: Oncoimmunology Issue: Volume 7:Number 6(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial. Issue 5 (May 2018) Authors: Wrangle, John M; Velcheti, Vamsidhar; Patel, Manish R; Garrett-Mayer, Elizabeth; Hill, Elizabeth G; Ravenel, James G; Miller, Jeffrey S; Farhad, Mohammad; Anderton, Kate; Lindsey, Kathryn; Taffaro-Neskey, Michele; Sherman, Carol; Suriano, Samantha; Swiderska-Syn, Marzena; Sion, Amy; Harris, Joni;... Journal: Lancet oncology Issue: Volume 19:Issue 5(2018) Page Start: 694 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗